Effective dose estimation for oncological and neurological PET/CT procedures
Abstract Background The aim of this study was to retrospectively evaluate the patient effective dose (ED) for different PET/CT procedures performed with a variety of PET radiopharmaceutical compounds. PET/CT studies of 210 patients were reviewed including Torso (n = 123), Whole body (WB) (n = 36), H...
Main Authors: | Josep M. Martí-Climent, Elena Prieto, Verónica Morán, Lidia Sancho, Macarena Rodríguez-Fraile, Javier Arbizu, María J. García-Velloso, José A. Richter |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2017-04-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13550-017-0272-5 |
Similar Items
-
Molecular imaging in oncology: Common PET/CT radiopharmaceuticals and applications
by: Elisa Franquet, et al.
Published: (2022-01-01) -
PET Oncological Radiopharmaceuticals: Current Status and Perspectives
by: Mai Lin, et al.
Published: (2022-10-01) -
FDG dose extravasations in PET/CT: frequency and impact on SUV measurements
by: Medhat M Osman, et al.
Published: (2011-11-01) -
PET/CT of the Spleen with Gallium-Oxine-Labeled, Heat-Damaged Red Blood Cells: Clinical Experience and Technical Aspects
by: Robert Drescher, et al.
Published: (2023-02-01) -
Will extended field-of-view PET/CT depopulate the graveyard of failed PET radiopharmaceuticals?
by: E. F. J. de Vries, et al.
Published: (2022-12-01)